2014
DOI: 10.1002/jcla.21815
|View full text |Cite
|
Sign up to set email alerts
|

Increased Igf‐I/Igfbp‐3 Ratios in Postmenopausal Taiwanese with Breast Cancer, Irrespective of Er and Pr Statuses and Her2 Expression in a Case–Control Study

Abstract: The ratios of IGF-I/IGFBP-3 were increased in postmenopausal Taiwanese women with BC, irrespective of their ages, ER and PR statuses, and HER2 expression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…The positive associations between the IGF‐1 and the risks of breast cancer, papillary thyroid cancer, and prostate cancer were found in the previous studies, 10 , 11 , 12 , 13 but the risk of gastric cancer decreased in the individuals with IGF‐1 gene rs2195239 polymorphism. 14 Nevertheless, no significant difference of IGF‐1 levels between the breast cancer patients and the controls was found in our previous study 15 and another studies. 16 , 17 In addition to the influences of menopausal statuses, 10 racial variations, 18 gene polymorphism, 14 and subtypes of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), 19 the associations between the IGF‐1 levels and biomarkers of skeletal muscles, liver function and bone modulation were worthy to investigate.…”
Section: Introductionmentioning
confidence: 65%
“…The positive associations between the IGF‐1 and the risks of breast cancer, papillary thyroid cancer, and prostate cancer were found in the previous studies, 10 , 11 , 12 , 13 but the risk of gastric cancer decreased in the individuals with IGF‐1 gene rs2195239 polymorphism. 14 Nevertheless, no significant difference of IGF‐1 levels between the breast cancer patients and the controls was found in our previous study 15 and another studies. 16 , 17 In addition to the influences of menopausal statuses, 10 racial variations, 18 gene polymorphism, 14 and subtypes of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), 19 the associations between the IGF‐1 levels and biomarkers of skeletal muscles, liver function and bone modulation were worthy to investigate.…”
Section: Introductionmentioning
confidence: 65%
“…The change in IGF-1/IGFBP-3 ratio was statistically significant but modest (mean absolute change, 1.5 × 10 −3 ; percentage change, 4.3%). Whether this change is clinically relevant remains to be seen, however, comparable differences were seen between breast cancer cases and age-matched unaffected controls [ 36 ]. Since we did not adjust for multiple comparisons for the secondary biomarker endpoints, these results need to be interpreted with caution and confirmed in larger studies.…”
Section: Discussionmentioning
confidence: 99%